Omar K. Siddiqi, MD

Clinical Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Omar Siddiqi, MD is an Assistant Professor of Medicine in Cardiovascular Medicine at the Chobanian and Avedisian School of Medicine, and he is the Program Director of the Cardiovascular Medicine Fellowship Program. As director of the cardiology fellowship curriculum, he is credited with developing an academic half day for cardiovascular medicine fellows, developing an echocardiography curriculum utilizing the CAE echocardiography simulator housed in the Solomont Simulation Center, and starting an Imaging Show and Tell conference. These efforts have been recognized with two Cardiovascular Medicine Fellowship Faculty Teaching Awards which he won in 2015 and 2018. At the Chobanian and Avedisian School of Medicine, he serves as co-director of the second year medical school cardiovascular pathophysiology module. His research interests in medical education include the development of simulation-based curricula and the integration of team-based learning (TBL) in teaching ECGs. His clinical interests include cardiac amyloidosis and echocardiography, and he is an attending cardiologist in the BU Amyloidosis Center. His clinical research interests are around the assessment of novel therapies for the treatment of cardiac amyloidosis. He has served as Clinical Investigator of five studies, including two currently.

Publications

  • Published 4/17/2026

    Berumen A, Staron A, Kalaitzidis G, Siddiqi OK, Gopal DM, Ruberg FL, Sanchorawala V. Evaluating AL-ISS within a BNP-Based Model for AL Amyloidosis in the Daratumumab Era. Blood Adv. 2026 Apr 17. PMID: 41995749.

    Read at: PubMed

  • Published 4/10/2026

    Ferri GM, Urina-Jassir M, Stanisic AV, Hensien JM, Lee G, Sullivan N, Siddiqi OK. Finding ferritin footprints in 5-fluorouracil-induced cardiotoxicity. Cardiooncology. 2026 Apr 10; 12(1). PMID: 41964070.

    Read at: PubMed

  • Published 12/3/2025

    Siddiqi HK, Bhatt K, Gopal DM, Siddiqi OK. Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis. J Am Coll Cardiol. 2026 Feb 10; 87(5):502-504. PMID: 41335083.

    Read at: PubMed

  • Published 5/27/2025

    Siddiqi OK, Ruberg FL, Gopal DM. Impact of Vutrisiran on Functional Capacity and Quality of Life in ATTR Cardiomyopathy: HELIOS-B Analysis. J Am Coll Cardiol. 2025 May 27; 85(20):1956-1958. PMID: 40398974.

    Read at: PubMed

  • Published 3/30/2025

    Rao SV, Brooks MM, D'Agostino HEA, Steg PG, Simon T, Aronow HD, Goldsweig AM, Malik S, Alsweiler C, Ho KKL, Dehghani P, Caixeta A, Quraishi AR, Robinson S, Traverse JH, Siddiqi O, Fergusson DA, Potter BJ, Schulman-Marcus J, Keating FK, Carson JL. Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients With Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial. Circ Cardiovasc Interv. 2025 May; 18(5):e015249. PMID: 40159118.

    Read at: PubMed

View All 37 Publications:   View Full Profile in BUMC

Other Positions

  • Member, Amyloidosis Center
    Boston University

Websites

Education

  • Washington University School of Medicine, MD
  • University of Rhode Island, BS

View all profiles